References
1. McCabe, B. F. 1979. “Autoimmune Sensorineural Hearing Loss.”Annals of Otology, Rhinology & Laryngology 88 (5): 585–89.
https://doi.org/10.1177/000348947908800501.
2. Ciorba, A., Corazzi V., Bianchini C., Aimoni, C., Pelucchi S.,
Skarżyński, P. H., and Hatzopoulos, S. 2018. “Autoimmune Inner Ear
Disease (AIED): A Diagnostic Challenge.” International Journal of
Immunopathology and Pharmacology 32 (March): 205873841880868.
https://doi.org/10.1177/2058738418808680.
3. Shamriz, O., Tal Y., and Gross, M. 2018. “Autoimmune Inner Ear
Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic
Modalities of Cogan’s Syndrome.” Journal of Immunology Research 2018 (April): 1498640. https://doi.org/10.1155/2018/1498640.
4. Oz, R. S., Gluth, M., and Tesher, M. S. 2019. “Pediatric Autoimmune
Inner Ear Disease: A Rare, but Treatable Condition.” Pediatric
Annals 48 (10). https://doi.org/10.3928/19382359-20190923-01.
5. Vambutas, A., and Pathak, S. 2016. “AAO: Autoimmune and
Autoinflammatory (Disease) in Otology: What Is New in Immune-Mediated
Hearing Loss.” Laryngoscope Investigative Otolaryngology 1 (5):
110–15. https://doi.org/10.1002/lio2.28.
6. Strum, D., Kim S., Shim, T., and Monfared, A. 2020. “An Update on
Autoimmune Inner Ear Disease: A Systematic Review of Pharmacotherapy.”American Journal of Otolaryngology 41 (1): 102310.
https://doi.org/10.1016/j.amjoto.2019.102310.
7. Matsuoka, A. J., and Harris, J. P. 2013. “Autoimmune Inner Ear
Disease: A Retrospective Review of Forty-Seven Patients.”Audiology and Neuro-Otology 18 (4): 228–39.
https://doi.org/10.1159/000351289.
8. Sakano, H., and Harris, J. P. 2018. “Emerging Options in
Immune-Mediated Hearing Loss.” Laryngoscope Investigative
Otolaryngology 4 (1): 102–8. https://doi.org/10.1002/lio2.205.
9. Ho, E. C., and Yao, G. L. 2016. “Autoimmune Inner Ear Disease
Presenting as Menière’s Disease.” The Journal of Laryngology &
Otology 130 (S3): S175–75.
https://doi.org/10.1017/s0022215116005569.
10. Alexander, T. H., Weisman, M. H., Derebery, J. M., Espeland, M. A.,
Gantz, B. J., Gulya, A. J., Hammerschlag, P.E., et al. 2009. “Safety of
High-Dose Corticosteroids for the Treatment of Autoimmune Inner Ear
Disease.” Otology & Neurotology 30 (4): 443.
https://doi.org/10.1097/MAO.0b013e3181a52773.
11. Balouch, B., Meehan, R., Suresh, A., Zaheer, H.A., Jabir, A. R.,
Qatanani, A. M., Suresh, V., Kaleem, S. Z., and McKinnon, B. J. 2022.
“Use of Biologics for Treatment of Autoimmune Inner Ear Disease.”American Journal of Otolaryngology 43 (5): 103576–76.
https://doi.org/10.1016/j.amjoto.2022.103576.
12. Huang, K. L., Lin, H. C., Lin, C. D., and Wu, P. C. 2023.
“Relapsing Autoimmune Inner Ear Disease with Significant Response to
Methotrexate and Azathioprine Combination Therapy: A Case Report and
Mini Literature Review.” Medicine 102 (23): e33889–89.
https://doi.org/10.1097/md.0000000000033889.
13. Heywood, R. L., Hadavi, S., Donnelly, S., and Patel, N. 2013.
“Infliximab for Autoimmune Inner Ear Disease: Case Report and
Literature Review.” The Journal of Laryngology & Otology 127
(11): 1145–47. https://doi.org/10.1017/s002221511300217x.
14. Staecker, H., and Lefebvre P. P. 2002. “Autoimmune Sensorineural
Hearing Loss Improved by Tumor Necrosis Factor-α Blockade: A Case
Report.” Acta Oto-Laryngologica 122 (6): 684–87.
https://doi.org/10.1080/000164802320396402.
15. Cohen, S., Shoup, A., Weisman, M. H., and Harris, J. 2005.
“Etanercept Treatment for Autoimmune Inner Ear Disease: Results of a
Pilot Placebo-Controlled Study.” Otology & Neurotology 26 (5):
903–7. https://doi.org/10.1097/01.mao.0000185082.28598.87.
16. Pathak, S., Goldofsky, E., Vivas, E., Bonagura, V.R., and Vambutas,
A. 2011. “IL-1β Is Overexpressed and Aberrantly Regulated in
Corticosteroid Nonresponders with Autoimmune Inner Ear Disease.”Journal of Immunology 186 (3): 1870–79.
https://doi.org/10.4049/jimmunol.1002275.